Riskpilot← Back to searchSign inGet full accessDjurgårdskliniken AB
ABActiveOrg 5563383511Oxenstiernsgatan 33 BvMedical specialists activities · NACE 8622Est. 19880 employees
Revenue 2024
SEK 9K
-50% vs 2023
EBITDA margin
-77.8%
-75% vs 2023
Equity ratio
62.7%
Financial strength
Net profit 2024
SEK -7K
-75% vs 2023
| Revenue | SEK 9K | -50% |
| EBITDA | SEK -7K | -75% |
| Net profit | SEK -7K | -75% |
| Total assets | SEK 158K | -2% |
| Equity | SEK 99K | -7% |
| Employees | 0 | — |
Legal name
Djurgårdskliniken AB
Org number
5563383511
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
31 oktober 1988
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukvård och medicinsk forskning, entre- prenadverksamhet avseende tjänster inom hälso- och sjukvård, försäljning av sjukvårdsartiklar, äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Oxenstiernsgatan 33 Bv
Phone
+46707224280
Email
bmt@djurgardsklinkiken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 44 | 21 | 27 | 18 | 9 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | −28 | −24 | −4 | −7 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −28 | −24 | −4 | −7 |
| Net financials | — | — | — | — | — |
| Profit before tax | 0 | −7 | −24 | −4 | −7 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −7 | −24 | −4 | −7 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 198 | 173 | 152 | 161 | 158 |
| Equity | 142 | 135 | 111 | 106 | 99 |
| Long-term debt | 26 | 30 | 33 | 47 | 51 |
| Short-term debt | 9 | 8 | 8 | 8 | 8 |
| Total debt | 35 | 38 | 41 | 55 | 59 |
EBITDA margin
-77.8%
This company
15.8%
Market median
-592% vs market
20202024
Equity ratio
62.7%
This company
38.2%
Market median
+64% vs market
20202024
Return on equity
-7.1%
This company
18.4%
Market median
-139% vs market
20202024
Net profit margin
-77.8%
This company
8.1%
Market median
-1060% vs market
20202024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20202024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KB Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Djurgårdskliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kerstin Britt Marie Toregard | Chief Executive Officer | 0 companies |
| Carl Axel Thomas Carlsson | Deputy Board Member | 0 companies |